HealthNotableSingle-sourceDeveloping
5.0
Lantus Solostar insulin pen supply constraints reported despite lack of official FDA shortage status
STAT NewsLO·US·3 days ago
Investor Renato de Castro Longo Furtado Vianna is negotiating access to advanced pharmaceutical manufacturing technology in China to address Brazil's structural dependence on imported equipment. The initiative aims to accelerate the domestic adoption of complex technical processes currently unavailable in the Brazilian market.